➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Dow
Harvard Business School
McKinsey
Moodys

Last Updated: January 18, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Orteronel

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Orteronel?

Orteronel is an investigational drug.

There have been 17 clinical trials for Orteronel. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2012.

The most common disease conditions in clinical trials are Prostatic Neoplasms, Breast Neoplasms, and Ovarian Neoplasms. The leading clinical trial sponsors are Millennium Pharmaceuticals, Inc., National Cancer Institute (NCI), and University of Wisconsin, Madison.

Recent Clinical Trials for Orteronel
TitleSponsorPhase
AR-inhibitor Bicalutamide in Treating Patients With TNBCJiangsu Province Hospital of Traditional Chinese MedicinePhase 2
AR-inhibitor Bicalutamide in Treating Patients With TNBCNanning Second People's HospitalPhase 2
AR-inhibitor Bicalutamide in Treating Patients With TNBCThe First People's Hospital of LianyungangPhase 2

See all Orteronel clinical trials

Clinical Trial Summary for Orteronel

Top disease conditions for Orteronel
Top clinical trial sponsors for Orteronel

See all Orteronel clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Dow
Harvard Business School
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.